MODERN METHODS OF TREATMENT OF NON-SPECIFIC ULCERATIVE COLITIS

Abstract

Resume The treatment of NSUC should be selected optimally for each patient. It depends on the severity, prevalence, duration and complications of the disease. Treatment procedures are aimed at improving the patient's quality of life, achieving clinical remission and preventing complications. Group 1 drugs inhibit the production of prostaglandins, reduce the activity of neutrophils and the synthesis of IL-1, IL-6. Group 2 drugs accumulate in the affected area, stop the formation of arachidonic acid, block the synthesis of prostaglandins and leukotrienes, and suppress the chemotaxis of immune system cells. Group 3 drugs are an adjunct in the treatment of NSUC and are mainly recommended for hormone-dependent patients. Drugs of the 4th group are modern biological gene engineering drugs, which are more specific and highly effective compared to the drugs of the previous group.